Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 131.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 137.50p
  • 52 Week Low: 100.50p
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 818
  • Market Cap: 139.16m
  • RiskGrade: 54

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-19 Interim 79.52 4.66 4.08p 1.15p

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 169.87 3.79 8.14p 11.3 0.9 +12% 2.60p 2.8%
31-Dec-15 156.74 5.03 8.72p 10.1 1.4 +7% 2.86p 3.2%
31-Dec-16 165.27 (1.69) 8.66p 11.9 n/a -1% 3.40p 3.3%
31-Dec-17 170.29 5.82 7.93p 16.9 n/a -8% 3.50p 2.6%
31-Dec-18 165.57 8.42 9.02p 12.3 0.9 +14% 3.80p 3.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 169.85 13.17 9.32p 14.0 4.2 +3% 4.08p 3.1%
31-Dec-20 178.49 14.37 10.20p 12.8 1.4 +9% 4.37p 3.3%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 11.30 10.09 12.50 1.16

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Cello Health Market Data

Currency UK Pounds
Share Price 131.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 137.50p
52 Week Low 100.50p
Volume 818
Shares Issued 106.23m
Market Cap 139.16m
RiskGrade 54

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.75% below the market average61.75% below the market average61.75% below the market average61.75% below the market average61.75% below the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average
Price Trend
42.83% above the market average42.83% above the market average42.83% above the market average42.83% above the market average42.83% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
9.38% above the market average9.38% above the market average9.38% above the market average9.38% above the market average9.38% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Growth
32.09% below the market average32.09% below the market average32.09% below the market average32.09% below the market average32.09% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 06-Dec-2019

Time Volume / Share Price
15:08 785 @ 130.50p
14:08 15 @ 130.50p
14:07 18 @ 130.50p

Cello Health Key Personnel

CEO Mark Scott

Top of Page